ТОО "DOTOX"
This is a company preview
Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.
Risks
1/18Комитет государственных доходов · Государственные закупки РК · АО ФНБ «Самрук-Казына» · АОО «НИШ»Комитет государственных доходов · data as of 10.11.2026
Комитет государственных доходов · data up to 14.01.2026
This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.
Procurement signals
Court cases
Arrests & encumbrances
Enforcement proceedings
Certificates
Licenses and permits
Summary
Министерство юстиции РКActivities
1ОКЭДОбщая врачебная практика
Contacts
Change history
Financial statements
PremiumPublic contracts
What it sells and where
Samruk-Kazyna procurement
Tender bids
Procurement as a customer
Assets
Bank accounts
Leadership
2- КШ
Кадралин Шыңғыс Ержанұлы
Director
Former directors
- ГВГРИШЕНКОВ ВИКТОР ВЛАДИМИРОВИЧ
Founders
Accreditations
Employees
Affiliated companies
PremiumDirector's involvement in other legal entities
Branches
Company networks
PremiumSimilar companies
Media mentions
Company summary
ТОО "DOTOX" (BIN 081040003605) is an active legal entity in Восточно-Казахстанская область, registered in 2008 (18 years on the market). Primary activity — общая врачебная практика. Automated screening found 1 risk indicator for "DOTOX". Director on record — Кадралин Шыңғыс Ержанұлы. Data current as of November 10, 2026.
Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.